FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and Is BPC 157 Banned? Oral vs. Injectable Forms Explained Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review FDA Moves to Reevaluate Several Peptides American Med Spa Association